Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Medical Cannabis Treatment
    • 1.4.3 Capsaicin-derived Treatment
    • 1.4.4 Menthol-containing Treatment
    • 1.4.5 Omega 3 fatty acid-containing Treatment
    • 1.4.6 Botulinum Toxins
  • 1.5 Market by Application
    • 1.5.1 Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Orthopaedic and Musculoskeletal Pain
    • 1.5.3 Neuropathic Pain
    • 1.5.4 Cancer Pain
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Non-Opioid Pain Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Non-Opioid Pain Treatment Industry
      • 1.6.1.1 Non-Opioid Pain Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Non-Opioid Pain Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Non-Opioid Pain Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Non-Opioid Pain Treatment Market Perspective (2015-2026)
  • 2.2 Non-Opioid Pain Treatment Growth Trends by Regions
    • 2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Non-Opioid Pain Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Non-Opioid Pain Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-Opioid Pain Treatment Players by Market Size
    • 3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Non-Opioid Pain Treatment Market Concentration Ratio
    • 3.2.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2019
  • 3.3 Non-Opioid Pain Treatment Key Players Head office and Area Served
  • 3.4 Key Players Non-Opioid Pain Treatment Product Solution and Service
  • 3.5 Date of Enter into Non-Opioid Pain Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2021-2026)

5 Non-Opioid Pain Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Non-Opioid Pain Treatment Market Size by Application (2015-2020)
  • 5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Non-Opioid Pain Treatment Market Size (2015-2020)
  • 6.2 Non-Opioid Pain Treatment Key Players in North America (2019-2020)
  • 6.3 North America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 6.4 North America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Non-Opioid Pain Treatment Market Size (2015-2020)
  • 7.2 Non-Opioid Pain Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Non-Opioid Pain Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Non-Opioid Pain Treatment Market Size (2015-2020)
  • 8.2 Non-Opioid Pain Treatment Key Players in China (2019-2020)
  • 8.3 China Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 8.4 China Non-Opioid Pain Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Non-Opioid Pain Treatment Market Size (2015-2020)
  • 9.2 Non-Opioid Pain Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Non-Opioid Pain Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Non-Opioid Pain Treatment Market Size (2015-2020)
  • 10.2 Non-Opioid Pain Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Non-Opioid Pain Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Non-Opioid Pain Treatment Market Size (2015-2020)
  • 11.2 Non-Opioid Pain Treatment Key Players in India (2019-2020)
  • 11.3 India Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 11.4 India Non-Opioid Pain Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Non-Opioid Pain Treatment Market Size (2015-2020)
  • 12.2 Non-Opioid Pain Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Non-Opioid Pain Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Non-Opioid Pain Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Allergan PLC
    • 13.1.1 Allergan PLC Company Details
    • 13.1.2 Allergan PLC Business Overview and Its Total Revenue
    • 13.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
    • 13.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2015-2020))
    • 13.1.5 Allergan PLC Recent Development
  • 13.2 Canopy Growth
    • 13.2.1 Canopy Growth Company Details
    • 13.2.2 Canopy Growth Business Overview and Its Total Revenue
    • 13.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
    • 13.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.2.5 Canopy Growth Recent Development
  • 13.3 Medical Marijuana Inc.
    • 13.3.1 Medical Marijuana Inc. Company Details
    • 13.3.2 Medical Marijuana Inc. Business Overview and Its Total Revenue
    • 13.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
    • 13.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.3.5 Medical Marijuana Inc. Recent Development
  • 13.4 Panag Pharma Inc.
    • 13.4.1 Panag Pharma Inc. Company Details
    • 13.4.2 Panag Pharma Inc. Business Overview and Its Total Revenue
    • 13.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
    • 13.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.4.5 Panag Pharma Inc. Recent Development
  • 13.5 Tilray
    • 13.5.1 Tilray Company Details
    • 13.5.2 Tilray Business Overview and Its Total Revenue
    • 13.5.3 Tilray Non-Opioid Pain Treatment Introduction
    • 13.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.5.5 Tilray Recent Development
  • 13.6 Aphria Inc.
    • 13.6.1 Aphria Inc. Company Details
    • 13.6.2 Aphria Inc. Business Overview and Its Total Revenue
    • 13.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
    • 13.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.6.5 Aphria Inc. Recent Development
  • 13.7 Bedrocan
    • 13.7.1 Bedrocan Company Details
    • 13.7.2 Bedrocan Business Overview and Its Total Revenue
    • 13.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
    • 13.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.7.5 Bedrocan Recent Development
  • 13.8 Cara Therapeutics
    • 13.8.1 Cara Therapeutics Company Details
    • 13.8.2 Cara Therapeutics Business Overview and Its Total Revenue
    • 13.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
    • 13.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.8.5 Cara Therapeutics Recent Development
  • 13.9 Centrexion Therapeutics
    • 13.9.1 Centrexion Therapeutics Company Details
    • 13.9.2 Centrexion Therapeutics Business Overview and Its Total Revenue
    • 13.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
    • 13.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.9.5 Centrexion Therapeutics Recent Development
  • 13.10 CHT Medical
    • 13.10.1 CHT Medical Company Details
    • 13.10.2 CHT Medical Business Overview and Its Total Revenue
    • 13.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
    • 13.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 13.10.5 CHT Medical Recent Development
  • 13.11 Cronos Group
    • 10.11.1 Cronos Group Company Details
    • 10.11.2 Cronos Group Business Overview and Its Total Revenue
    • 10.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
    • 10.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 10.11.5 Cronos Group Recent Development
  • 13.12 GW Pharmaceuticals
    • 10.12.1 GW Pharmaceuticals Company Details
    • 10.12.2 GW Pharmaceuticals Business Overview and Its Total Revenue
    • 10.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
    • 10.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 10.12.5 GW Pharmaceuticals Recent Development
  • 13.13 Medropharm Gmbh
    • 10.13.1 Medropharm Gmbh Company Details
    • 10.13.2 Medropharm Gmbh Business Overview and Its Total Revenue
    • 10.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
    • 10.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 10.13.5 Medropharm Gmbh Recent Development
  • 13.14 US Worldmeds LLC
    • 10.14.1 US Worldmeds LLC Company Details
    • 10.14.2 US Worldmeds LLC Business Overview and Its Total Revenue
    • 10.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
    • 10.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2015-2020)
    • 10.14.5 US Worldmeds LLC Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Non-Opioid Pain Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Opioid Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Allergan PLC
    Canopy Growth
    Medical Marijuana Inc.
    Panag Pharma Inc.
    Tilray
    Aphria Inc.
    Bedrocan
    Cara Therapeutics
    Centrexion Therapeutics
    CHT Medical
    Cronos Group
    GW Pharmaceuticals
    Medropharm Gmbh
    US Worldmeds LLC

    Market segment by Type, the product can be split into
    Medical Cannabis Treatment
    Capsaicin-derived Treatment
    Menthol-containing Treatment
    Omega 3 fatty acid-containing Treatment
    Botulinum Toxins
    Market segment by Application, split into
    Orthopaedic and Musculoskeletal Pain
    Neuropathic Pain
    Cancer Pain
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Non-Opioid Pain Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Non-Opioid Pain Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Non-Opioid Pain Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now